Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer
Human Mutation · 2026
DOI: 10.1155/humu/2744471 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Mutation, 2026. Verfasst von Hui Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Affiliated Tumor Hospital of Nantong University and Nantong Tumor Hospital, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, Signal Transduction, Drug Resistance, Neoplasm. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nantong Municipal Science and Technology Bureau.
Abstract (Originalsprache)
As a major cause of cancer‐related death globally, colorectal cancer (CRC) remains largely refractory to immunotherapy outside the context of microsatellite instability‐high (MSI‐H). This limited efficacy stems largely from the complex crosstalk within the tumor microenvironment (TME), which fosters immunosuppression and resistance. Our review analyzes the impact of dysregulated pathways—such as PD‐1/PD‐L1, cGAS/STING, Notch, and cytokine signaling—on the functional states of T cells, B cells, macrophages, dendritic cells, and NK cells in CRC. We investigate how these pathways underpin critical processes such as immune evasion, T cell exhaustion, and the protumor polarization of innate immune cells, thereby fostering a permissive niche for tumor growth and resistance to checkpoint inhibitors. The discussion also covers emerging biomarkers and innovative strategies, including combination therapies targeting pivotal signaling nodes, to reprogram the immune landscape. A deeper mechanistic understanding of these immunoregulatory pathways is essential for developing effective treatments to overcome resistance and improve patient prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory Medicine, Affiliated Tumor Hospital of Nantong University and Nantong Tumor Hospital, Nantong, Jiangsu, China.
- Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University and Nantong Tumor Hospital, Nantong, Jiangsu, China.
- Department of Oncology, Affiliated Tumor Hospital of Nantong University and Nantong Tumor Hospital, Nantong, Jiangsu, China.
- Institute of Oncology, Affiliated Tumor Hospital of Nantong University and Nantong Tumor Hospital, Nantong, Jiangsu, China, onko-i.si.
ORCID-Profile: Hui Zhang, Jingjing Shao, Tianye Zhao, Yaxuan Wang, Lili Shao, Haixia Zhu, Jibin Liu
Förderung
- Nantong Municipal Science and Technology Bureau
Zitieren
APA
Zhang, H., Shao, J., Zhao, T., Wang, Y., Shao, L., Zhu, H., Liu, J., & Zhang, L. (2026). Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer. Human Mutation. https://doi.org/10.1155/humu/2744471
Vancouver
Zhang H, Shao J, Zhao T, Wang Y, Shao L, Zhu H, et al. Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer. Human Mutation. 2026. doi:10.1155/humu/2744471
BibTeX
@article{Zhang2026,
author = {Zhang, Hui and Shao, Jingjing and Zhao, Tianye and Wang, Yaxuan and Shao, Lili and Zhu, Haixia and Liu, Jibin and Zhang, Lin},
title = {Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer},
journal = {Human Mutation},
year = {2026},
doi = {10.1155/humu/2744471}
}
EUVIMED